IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Gland Pharma Limited is an Pharmaceutical based company, located in Hyderabad, Gland Pharma Limited IPO size was 6479.55 Cr. and was issued at 1500.00 per share. The share of Gland Pharma Limited were listed at 1820.45 per share and are currently trading at 1449.40 per share.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Manufactures critical high-voltage equipment for High Voltage Direct Current (HVDC) and Flexible AC Transmission Systems (FACTS) networks, enabling energy transition from renewable sources to power gr
Sangli
business of global digital and technology services with artificial intelligence.
Mumbai
Gland Pharma operates in Pharmaceutical and Manufactures Inject Tables. The Issue is listed on BSE,NSE in Nov, 2020. Gland Pharma IPO size was 6479.55 Cr. with Issue price of 1500.00 .
Merchant Banker(s) of Gland Pharma IPO: Citigroup Global Markets India Private Limited , Haitong Securities India Private Limited , Kotak Mahindra Capital Company Limited , Nomura Financial Advisory And Securities (India) Private Limited
Gland Pharma IPO subscription was 2.06 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Gland Pharma IPO listed at a listing price of 1820.45 against the offer price of 1500.00.
The current market price of Gland Pharma is 1449.40.
Why Us?
